Pyrazolo[3,4-d]pyrimidines as tyrosine kinase inhibitors: synthesis and biological evaluation

Testo completo

(1)PO - 52. ,;*LRUQDWH,WDOR)UDQFHVLGL&KLPLFD ,;-RXUQpHV)UDQFR,WDOLHQQHVGH&KLPLH *HQRYD $SULO. . ! "

(2) #$% G&! ! ' ( ) ! (

(3) *

(4)

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

(6)